
Biotechnology
Regeneron to buy 23andMe and its user data for $256M
Pharmaceutical giant Regeneron announced Monday that it will acquire genetic testing company 23andMe for $256 million, following a court-supervised bankruptcy auction. The deal, if approved, will grant Regeneron ownership of 23andMe’s genomics service and a massive trove of personal and genetic data from roughly 15 million customers. The acquisition